Ursodeoxycholic Acid API Market Size, Share, Application Trends and Global Outlook 2025-2031 | ICE, Daewoong Chemical, PharmaZell GmbH

Market Summary -

The global market for Ursodeoxycholic Acid API was estimated to be worth US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.

Accourding to QY Research has released a new publication titled "Global Ursodeoxycholic Acid API Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This comprehensive study provides an in-depth evaluation of the worldwide Ursodeoxycholic Acid API industry, uncovering the major forces influencing market growth and delivering high-value insights for investors, industry leaders, and strategic decision-makers. The report examines critical elements such as market dynamics, evolving technologies, segmentation trends, regional developments, and the competitive landscape. With data backed by rigorous research and expert interpretation, it offers an authoritative guide to understanding the macroeconomic and microeconomic factors reshaping the global market.

Get Full PDF Sample Copy of the Report: (Including Full TOC, Tables & Charts): https://www.qyresearch.in/request-sample/chemical-material-ursodeoxycholic-acid-api-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ursodeoxycholic Acid API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.

The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) API market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA API as a key component in manufacturing medications to address these conditions.

However, the UDCA API market faces several challenges, with regulatory hurdles and price pressures being significant constraints. The stringent approval requirements and the need for high-quality production standards in API manufacturing can delay the market entry of new players and increase operational costs. Furthermore, with the increasing production of generic UDCA products, competition has intensified, leading to a decrease in profit margins for manufacturers of branded UDCA drugs. Another challenge is the limited scope of UDCA applications, as the drug is effective primarily for a specific set of liver conditions, limiting its broader market appeal. Additionally, supply chain disruptions and raw material price fluctuations for manufacturing UDCA can affect the availability and cost-effectiveness of APIs, further complicating market dynamics.

Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top five players hold a share about 81%.

Recent Developments -

The authors of the report have put forward recent developments by key participants. Other strategic activities by manufacturers such as M&A, joint ventures, collaborations, innovation, product offerings, and research and development activities are highlighted in this research study. This will keep the users up-to-date about the undertakings and give the users a crystal-clear understanding of the key advancements emerging in the business.

Market Drivers, Challenges & Restraints -

This section outlines the various elements influencing the trajectory of the Ursodeoxycholic Acid API market:

Key Growth Drivers -

- Supportive policy frameworks and regulatory reforms
- Advancement in product innovation and technological breakthroughs
- Growing demand in emerging application areas
- Shift in global supply chain structures

Restraints & Challenges -

- Regulatory uncertainties
- Competitive pricing pressures
- Operational risks
- Market-entry barriers

Market Segmentation and Regional -

By Type

Chemical Method
Enzyme Method

By Application

Tablets
Capsules
Suspensions

Regional Analysis -

✔ North America (U.S., Canada, China)
✔ Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
✔ Asia-Pacific (Japan, South Korea, China Taiwan, Southeast Asia, India)
✔ Middle East, Africa, Latin America (Brazil, Mexico, Turkey, Israel, GCC Countries)

The analysis spans from 2024 (base year) to 2031 (forecast period).

Major Company Included: -

ICE
Zhongshan Bailing
Daewoong Chemical
PharmaZell GmbH
Dipharma Francis
Suzhou Tianlv
Sichuan Xieli
Chuanning Bio
Shilpa medicare
Symbio generics
Arch Pharma

Request for Pre-Order / Enquiry Link: https://www.qyresearch.in/pre-order-inquiry/chemical-material-ursodeoxycholic-acid-api-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why should you purchase this report?

Purchasing this report provides you with a comprehensive and data-driven understanding of the market landscape, enabling informed business decisions and strategic planning. The report comes with free customization based on client requirements, including a country-level breakdown of any five countries of your choice and a competitive analysis of segment revenue by key market players. With detailed insights into market trends, growth drivers, challenges, competitive dynamics, and emerging opportunities, this report equips stakeholders, manufacturers, and investors with actionable intelligence to identify profitable prospects, optimize operations, and maintain a competitive edge in the industry.

How Can the Research Study Help your Business?

✔ The information presented in the Ursodeoxycholic Acid API report helps your decision makers to become prudent and make the best business choices.
✔ The report enables you to see the future of the global Ursodeoxycholic Acid API market and accordingly take decisions that will be in the best interest of your business.
✔ It offers you a forward-looking perspective of the global Ursodeoxycholic Acid API market drivers and how you can secure significant market gains in the near future.
✔ It provides SWOT analysis of the global Ursodeoxycholic Acid API market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.
✔ It also assesses the changing competitive dynamics of the global Ursodeoxycholic Acid API market using pin-point evaluation.

Key Questions Answered in the Report -

✔ What is the size and estimated growth rate of the global and regional Ursodeoxycholic Acid API market?
✔ Which countries are expected to display the strongest growth?
✔ Which region will dominate the market throughout the forecast period?
✔ What are the main factors driving or restraining market expansion?
✔ What technological advancements are shaping future demand?
✔ Where are the key opportunities for new entrants and established players?
✔ Which companies currently hold the highest market share?
✔ How will market dynamics evolve from 2025 to 2031?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Ursodeoxycholic Acid API Product Introduction
1.2 Global Ursodeoxycholic Acid API Market Size Forecast
1.2.1 Global Ursodeoxycholic Acid API Sales Value (2020-2031)
1.2.2 Global Ursodeoxycholic Acid API Sales Volume (2020-2031)
1.2.3 Global Ursodeoxycholic Acid API Sales Price (2020-2031)
1.3 Ursodeoxycholic Acid API Market Trends & Drivers
1.3.1 Ursodeoxycholic Acid API Industry Trends
1.3.2 Ursodeoxycholic Acid API Market Drivers & Opportunity
1.3.3 Ursodeoxycholic Acid API Market Challenges
1.3.4 Ursodeoxycholic Acid API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ursodeoxycholic Acid API Players Revenue Ranking (2024)
2.2 Global Ursodeoxycholic Acid API Revenue by Company (2020-2025)
2.3 Global Ursodeoxycholic Acid API Players Sales Volume Ranking (2024)
2.4 Global Ursodeoxycholic Acid API Sales Volume by Company Players (2020-2025)
2.5 Global Ursodeoxycholic Acid API Average Price by Company (2020-2025)
2.6 Key Manufacturers Ursodeoxycholic Acid API Manufacturing Base and Headquarters
2.7 Key Manufacturers Ursodeoxycholic Acid API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ursodeoxycholic Acid API
2.9 Ursodeoxycholic Acid API Market Competitive Analysis
2.9.1 Ursodeoxycholic Acid API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ursodeoxycholic Acid API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ursodeoxycholic Acid API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemical Method
3.1.2 Enzyme Method
3.2 Global Ursodeoxycholic Acid API Sales Value by Type
3.2.1 Global Ursodeoxycholic Acid API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ursodeoxycholic Acid API Sales Value, by Type (2020-2031)
3.2.3 Global Ursodeoxycholic Acid API Sales Value, by Type (%) (2020-2031)
3.3 Global Ursodeoxycholic Acid API Sales Volume by Type
3.3.1 Global Ursodeoxycholic Acid API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ursodeoxycholic Acid API Sales Volume, by Type (2020-2031)
3.3.3 Global Ursodeoxycholic Acid API Sales Volume, by Type (%) (2020-2031)
3.4 Global Ursodeoxycholic Acid API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Capsules
4.1.3 Suspensions
4.2 Global Ursodeoxycholic Acid API Sales Value by Application
4.2.1 Global Ursodeoxycholic Acid API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ursodeoxycholic Acid API Sales Value, by Application (2020-2031)
4.2.3 Global Ursodeoxycholic Acid API Sales Value, by Application (%) (2020-2031)
4.3 Global Ursodeoxycholic Acid API Sales Volume by Application
4.3.1 Global Ursodeoxycholic Acid API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ursodeoxycholic Acid API Sales Volume, by Application (2020-2031)
4.3.3 Global Ursodeoxycholic Acid API Sales Volume, by Application (%) (2020-2031)
4.4 Global Ursodeoxycholic Acid API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ursodeoxycholic Acid API Sales Value by Region
5.1.1 Global Ursodeoxycholic Acid API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ursodeoxycholic Acid API Sales Value by Region (2020-2025)
5.1.3 Global Ursodeoxycholic Acid API Sales Value by Region (2026-2031)
5.1.4 Global Ursodeoxycholic Acid API Sales Value by Region (%), (2020-2031)
5.2 Global Ursodeoxycholic Acid API Sales Volume by Region
5.2.1 Global Ursodeoxycholic Acid API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ursodeoxycholic Acid API Sales Volume by Region (2020-2025)
5.2.3 Global Ursodeoxycholic Acid API Sales Volume by Region (2026-2031)
5.2.4 Global Ursodeoxycholic Acid API Sales Volume by Region (%), (2020-2031)
5.3 Global Ursodeoxycholic Acid API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ursodeoxycholic Acid API Sales Value, 2020-2031
5.4.2 North America Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ursodeoxycholic Acid API Sales Value, 2020-2031
5.5.2 Europe Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ursodeoxycholic Acid API Sales Value, 2020-2031
5.6.2 Asia Pacific Ursodeoxycholic Acid API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ursodeoxycholic Acid API Sales Value, 2020-2031
5.7.2 South America Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ursodeoxycholic Acid API Sales Value, 2020-2031
5.8.2 Middle East & Africa Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ursodeoxycholic Acid API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ursodeoxycholic Acid API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Ursodeoxycholic Acid API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ursodeoxycholic Acid API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ursodeoxycholic Acid API Sales Value, 2020-2031
6.3.2 United States Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ursodeoxycholic Acid API Sales Value, 2020-2031
6.4.2 Europe Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ursodeoxycholic Acid API Sales Value, 2020-2031
6.5.2 China Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ursodeoxycholic Acid API Sales Value, 2020-2031
6.6.2 Japan Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ursodeoxycholic Acid API Sales Value, 2020-2031
6.7.2 South Korea Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ursodeoxycholic Acid API Sales Value, 2020-2031
6.8.2 Southeast Asia Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ursodeoxycholic Acid API Sales Value, 2020-2031
6.9.2 India Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 ICE
7.1.1 ICE Company Information
7.1.2 ICE Introduction and Business Overview
7.1.3 ICE Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 ICE Ursodeoxycholic Acid API Product Offerings
7.1.5 ICE Recent Development
7.2 Zhongshan Bailing
7.2.1 Zhongshan Bailing Company Information
7.2.2 Zhongshan Bailing Introduction and Business Overview
7.2.3 Zhongshan Bailing Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Zhongshan Bailing Ursodeoxycholic Acid API Product Offerings
7.2.5 Zhongshan Bailing Recent Development
7.3 Daewoong Chemical
7.3.1 Daewoong Chemical Company Information
7.3.2 Daewoong Chemical Introduction and Business Overview
7.3.3 Daewoong Chemical Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Daewoong Chemical Ursodeoxycholic Acid API Product Offerings
7.3.5 Daewoong Chemical Recent Development
7.4 PharmaZell GmbH
7.4.1 PharmaZell GmbH Company Information
7.4.2 PharmaZell GmbH Introduction and Business Overview
7.4.3 PharmaZell GmbH Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 PharmaZell GmbH Ursodeoxycholic Acid API Product Offerings
7.4.5 PharmaZell GmbH Recent Development
7.5 Dipharma Francis
7.5.1 Dipharma Francis Company Information
7.5.2 Dipharma Francis Introduction and Business Overview
7.5.3 Dipharma Francis Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Dipharma Francis Ursodeoxycholic Acid API Product Offerings
7.5.5 Dipharma Francis Recent Development
7.6 Suzhou Tianlv
7.6.1 Suzhou Tianlv Company Information
7.6.2 Suzhou Tianlv Introduction and Business Overview
7.6.3 Suzhou Tianlv Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Suzhou Tianlv Ursodeoxycholic Acid API Product Offerings
7.6.5 Suzhou Tianlv Recent Development
7.7 Sichuan Xieli
7.7.1 Sichuan Xieli Company Information
7.7.2 Sichuan Xieli Introduction and Business Overview
7.7.3 Sichuan Xieli Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sichuan Xieli Ursodeoxycholic Acid API Product Offerings
7.7.5 Sichuan Xieli Recent Development
7.8 Chuanning Bio
7.8.1 Chuanning Bio Company Information
7.8.2 Chuanning Bio Introduction and Business Overview
7.8.3 Chuanning Bio Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Chuanning Bio Ursodeoxycholic Acid API Product Offerings
7.8.5 Chuanning Bio Recent Development
7.9 Shilpa medicare
7.9.1 Shilpa medicare Company Information
7.9.2 Shilpa medicare Introduction and Business Overview
7.9.3 Shilpa medicare Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Shilpa medicare Ursodeoxycholic Acid API Product Offerings
7.9.5 Shilpa medicare Recent Development
7.10 Symbio generics
7.10.1 Symbio generics Company Information
7.10.2 Symbio generics Introduction and Business Overview
7.10.3 Symbio generics Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Symbio generics Ursodeoxycholic Acid API Product Offerings
7.10.5 Symbio generics Recent Development
7.11 Arch Pharma
7.11.1 Arch Pharma Company Information
7.11.2 Arch Pharma Introduction and Business Overview
7.11.3 Arch Pharma Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Arch Pharma Ursodeoxycholic Acid API Product Offerings
7.11.5 Arch Pharma Recent Development
8 Industry Chain Analysis
8.1 Ursodeoxycholic Acid API Industrial Chain
8.2 Ursodeoxycholic Acid API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ursodeoxycholic Acid API Sales Model
8.5.2 Sales Channel
8.5.3 Ursodeoxycholic Acid API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.